title: Infliximab and adalimumab-induced thrombocytopenia in a woman with colonic Crohn's disease.
authors.forename: Antonio
authors.initials: A
authors.lastname: Salar
authors.forename: Xavier
authors.initials: X
authors.lastname: Bessa
authors.forename: Eduard
authors.initials: E
authors.lastname: Muñiz
authors.forename: David
authors.initials: D
authors.lastname: Monfort
authors.forename: Carlos
authors.initials: C
authors.lastname: Besses
authors.forename: Montserrat
authors.initials: M
authors.lastname: Andreu
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D001772:Blood Cell Count; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D000069285:Infliximab; D013921:Thrombocytopenia / Q000139:chemically induced*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069285:Infliximab; D000068879:Adalimumab